Use of erythropoietin after solid organ transplantation.


Anaemia is common after solid organ transplantation. Although many impressive experimental data about the organoprotective properties of erythropoietin (EPO) have been reported, there are only scant clinical and experimental data about EPO use after solid organ transplantation. Since the treatment targets of anaemia in chronic kidney disease cannot be… (More)


Cite this paper

@article{Schwenger2007UseOE, title={Use of erythropoietin after solid organ transplantation.}, author={Vedat Schwenger and Christian Morath and Martin Zeier}, journal={Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association}, year={2007}, volume={22 Suppl 8}, pages={viii47-viii49} }